仙乐健康
(300791)
| 流通市值：45.85亿 | | | 总市值：54.98亿 |
| 流通股本：2.57亿 | | | 总股本：3.09亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,003,326,975.63 | 4,262,906,991.45 | 3,291,173,866.65 | 2,041,618,895.92 |
| 营业收入 | 1,003,326,975.63 | 4,262,906,991.45 | 3,291,173,866.65 | 2,041,618,895.92 |
| 利息收入 | - | 0 | - | - |
| 已赚保费 | - | 0 | - | - |
| 手续费及佣金收入 | - | 0 | - | - |
| 二、营业总成本 | 946,233,303.94 | 4,075,944,875.28 | 3,046,438,602.78 | 1,891,846,695.56 |
| 营业成本 | 678,459,326.19 | 2,959,813,107.81 | 2,229,386,326.65 | 1,364,132,984.92 |
| 利息支出 | - | 0 | - | - |
| 手续费及佣金支出 | - | 0 | - | - |
| 退保金 | - | 0 | - | - |
| 赔付支出净额 | - | 0 | - | - |
| 提取保险合同准备金净额 | - | 0 | - | - |
| 保单红利支出 | - | 0 | - | - |
| 分保费用 | - | 0 | - | - |
| 税金及附加 | 6,032,645.27 | 26,755,132.84 | 18,515,045.78 | 12,337,199.24 |
| 销售费用 | 86,483,237.43 | 373,186,497.98 | 273,442,676.89 | 176,929,539.18 |
| 管理费用 | 107,921,448.03 | 466,101,333.73 | 353,487,534.88 | 234,162,088.13 |
| 研发费用 | 30,120,715.15 | 145,936,008.53 | 100,513,939.25 | 62,163,531.68 |
| 财务费用 | 37,215,931.87 | 104,152,794.39 | 71,093,079.33 | 42,121,352.41 |
| 其中:利息费用 | 19,157,359.15 | 87,835,261.86 | 75,661,830.72 | 48,942,604.97 |
| 其中:利息收入 | 1,400,210.65 | 8,394,975.28 | 5,366,923.52 | 3,526,812.73 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -1,029,202.98 | 60,908,511.93 | 1,361,713.44 | 1,360,617.55 |
| 加:投资收益 | -2,149,996.27 | -6,382,723.74 | -2,178,133.11 | 355,524.37 |
| 净敞口套期收益 | - | 0 | - | - |
| 汇兑收益 | - | 0 | - | - |
| 资产处置收益 | 324.98 | 2,423,102.29 | 360,551.26 | -26,644.23 |
| 资产减值损失(新) | -533,955.3 | -269,174,690.97 | -9,215,691.68 | -8,278,945.26 |
| 信用减值损失(新) | -3,158,699.58 | -3,773,218.67 | -3,225,272.89 | 216,417.72 |
| 其他收益 | 2,717,217.17 | 37,402,974.95 | 28,960,516.24 | 8,002,839.4 |
| 四、营业利润 | 52,939,359.71 | 8,366,071.96 | 260,798,947.13 | 151,402,009.91 |
| 加:营业外收入 | 47,836.57 | 1,104,550.95 | 658,701.28 | 1,962,544.19 |
| 减:营业外支出 | 1,204,004.83 | 15,359,743.96 | 6,501,829.68 | 4,810,969.93 |
| 五、利润总额 | 51,783,191.45 | -5,889,121.05 | 254,955,818.73 | 148,553,584.17 |
| 减:所得税费用 | 9,855,081.79 | -26,289,708.32 | 33,122,608.71 | 12,293,566.25 |
| 六、净利润 | 41,928,109.66 | 20,400,587.27 | 221,833,210.02 | 136,260,017.92 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 41,928,109.66 | 20,400,587.27 | 221,833,210.02 | 136,260,017.92 |
| 终止经营净利润 | - | 0 | - | - |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 49,905,590.59 | 136,531,324.73 | 260,267,463.38 | 161,117,310.35 |
| 少数股东损益 | -7,977,480.93 | -116,130,737.46 | -38,434,253.36 | -24,857,292.43 |
| 扣除非经常损益后的净利润 | 50,086,251.74 | 74,239,832.3 | 244,445,836.24 | 159,488,146.1 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.16 | 0.45 | 0.85 | 0.53 |
| (二)稀释每股收益 | 0.16 | 0.45 | 0.85 | 0.53 |
| 八、其他综合收益 | -42,101,385.29 | 18,844,606.27 | 28,290,303.01 | 31,139,887.11 |
| 归属于母公司股东的其他综合收益 | -42,101,385.29 | 21,014,543.27 | 29,596,272.09 | 31,627,258.47 |
| 九、综合收益总额 | -173,275.63 | 39,245,193.54 | 250,123,513.03 | 167,399,905.03 |
| 归属于母公司股东的综合收益总额 | 7,804,205.29 | 157,545,868 | 289,863,735.47 | 192,744,568.82 |
| 归属于少数股东的综合收益总额 | -7,977,480.92 | -118,300,674.46 | -39,740,222.44 | -25,344,663.79 |
| 公告日期 | 2026-04-24 | 2026-04-24 | 2025-10-29 | 2025-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |